Sensus Healthcare has announced its newest introduction for non-melanoma skin cancer treatment at the 55th annual American Society of Therapeutic Radiation Oncology (ASTRO) in Atlanta, Ga. Sensus has an advanced SRT-100 superficial radiotherapy platform, featuring SharpBeam and has introduced the recently FDA-cleared technology that now allows you to "See what you Treat."
Mirada Medical has formalized an agreement with General Electric Healthcare, Milwaukee, Wis., whereby GE will license Mirada’s powerful automatic atlas-based contouring software for implementation on their AdvantageSim MD 9 virtual simulation software suite for advanced radiation therapy planning. The technology is based on Mirada Medical’s deformable registration software, which is widely regarded as best in class when aligning image data for RT planning.
An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also suggests that lung cancer patients who received intensity modulated radiation therapy (IMRT) reported less decline in their QOL compared to those receiving three-dimensional conformal radiation therapy (3-D CRT).
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Cianna Medical Inc., announced results of two new studies showing excellent longer-term outcomes with the SAVI breast brachytherapy applicator, including low recurrence rates, few toxicities, excellent cosmetic outcomes and high rates of survival. A third study demonstrated SAVI’s ability to precisely deliver radiation while avoiding critical structures. SAVI is a strut-based applicator that delivers accelerated partial breast irradiation (APBI), a five-day course of targeted radiation for early-stage breast cancer.
IBA (Ion Beam Applications S.A.) has launched an extension to the Visicoil product line at the annual ASTRO congress of the American Society for Radiation Oncology. This new design incorporates kV X-ray imaging compliant Visicoil Linear Markers pre-loaded in 21g and 22g needles that are almost half the size of needles typically used for placement of gold seeds.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
A shorter course of androgen suppression therapy prior to radiation therapy, when compared to a longer course of androgen suppression therapy, yields favorable outcomes and fewer adverse effects for intermediate-risk prostate cancer patients, according to research presented at the American Society for Radiation Oncology’s (ASTRO) 55th Annual Meeting. The study confirmed a disease-specific-survival (DSS) rate of 95 percent when patients received fewer weeks of neoadjuvant (NEO) total androgen suppression (TAS).
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
GE Healthcare reported that Silent Scan, a revolutionary technology that dramatically quiets magnetic resonance imaging (MRI) exams, is now commercially available and growing in clinical adoption around the world. Silent Scan addresses one of the most significant impediments to patient comfort — excessive acoustic noise generated during an MRI scan. Conventional MRI scanners can generate noise in excess of 110 decibels, roughly equivalent to rock concerts and requiring ear protection. GE’s exclusive Silent Scan technology is designed to reduce MR scanner noise to ambient (background) sound levels and improve a patient’s MRI exam experience.
When treated with stereotactic radiosurgery (SRS), that is not combined with whole brain radiotherapy (WBRT), adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. Younger patients (under 50 years old) were also found to be at no greater risk of new brain metastases developing despite omission of WBRT.
Cancer patients receiving radiotherapy (RT) who are potentially suffering from depression can be effectively identified by a two-item questionnaire, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Varian Medical Systems and Siemens Healthcare showcased a variety of solutions that bring together Siemens' world-class diagnostic imaging technologies with Varian's advanced therapeutic systems for treating cancer with image-guided radiotherapy, radiosurgery, and brachytherapy at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO).
Nucletron, an Elekta company has launched Esteya, a new approach for treating patients with skin cancer.
Elekta has introduced Monaco 5.0, which consolidates support for clinically useful delivery techniques in a single treatment planning system, and features refinements to planning speed and precision.
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
This August marked the 10th anniversary of the first production use of TeraMedica’s Evercore vendor neutral archive software.
Toshiba’s Vantage Titan 3.0T offers true comfort and flexibility with the power of 3.0T. The system is very quiet and features a large bore to put patients at ease. It also overcomes the clinical limitations of traditional 3.0T with advanced multi-port RF transmission technology, providing more uniformity and coverage to produce better body images.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
In an independent study presented during the North American Spine Society (NASS) Annual Meeting in October 2012, GE Healthcare’s OEC Elite 9900 mobile C-arm was rated the best in image quality and dose management.
Downey Breast Clinic recently selected PowerServer RIS/PACS/MU to manage their imaging center’s workflow and to gather the necessary data to attest for meaningful use.
Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
The American Society for Radiation Oncology (ASTRO) highlighted the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO’s 55th Annual Meeting, September 22-25, 2013, in Atlanta.
Healthcare providers looking for a versatile, scalable and patient-friendly computed tomography (CT) system now have a solution with the launch of Toshiba’s new Aquilion Prime. The system’s technologies deliver on customers’ clinical and financial needs of today and tomorrow.
TeraRecon announced positive ratings in the recently released KLAS 2013 Advanced Visualization performance report entitled “Advanced Visualization 2013: How Advanced Is It?” TeraRecon’s general performance ratings were particularly noteworthy, in that the company received the top scores for the following general indicators: